HB123 Summary

• Allows K-12 schools and other authorized entities (restaurants, recreation camps, youth sports leagues, amusement parks, sports arenas) to stock and administer epinephrine auto-injectors for treating anaphylaxis.

• Permits authorized health care providers to prescribe epinephrine auto-injectors in the name of schools or authorized entities, and allows pharmacists and physicians to dispense them under such prescriptions.

• Requires designated school personnel and authorized entity employees to complete anaphylaxis training programs initially and at least every two years, covering symptom recognition, storage and administration procedures, and emergency follow-up.

• Authorizes school nurses and designated personnel to administer epinephrine auto-injectors to any student or person believed to be experiencing anaphylaxis based on a standing protocol, regardless of prior prescription or allergy diagnosis.

• Provides immunity from liability for schools, authorized entities, health care providers, and trained personnel for ordinary negligence in administering, providing, or failing to administer epinephrine auto-injectors; immunity does not cover gross, willful, or wanton negligence.